Company Filing History:
10 out of 49 
1 out of 1 
1 out of 1 Years Active: 2012-2025
Title: Ann Chen: Innovator in Pharmaceutical Composition and Diagnostic Methods
Introduction
Ann Chen is a prominent inventor based in Taipei, Taiwan. She has made significant contributions to the field of pharmaceuticals and diagnostics, holding a total of 15 patents. Her work focuses on innovative solutions for treating autoimmune diseases and improving diagnostic methods for IgA nephropathy.
Latest Patents
Among her latest patents is a pharmaceutical composition that utilizes Tris (dibenzylideneacetone) dipalladium (Tris DBA) for treating autoimmune diseases. This invention provides a new use for Tris DBA, offering potential treatments for conditions such as multiple sclerosis, psoriasis, asthma, systemic lupus erythematosus, and lupus nephritis. Additionally, she has developed diagnostic kits and methods designed to rapidly and non-invasively determine physiologic levels of galactose-deficient IgA1 (Gd-IgA1) in patients suffering from IgA nephropathy. This invention includes a lectin-based diagnostic reagent and a method for detecting Gd-IgA1 using specific isolates.
Career Highlights
Ann Chen has worked at the National Defense Medical Center, where she has contributed to various research projects and innovations. Her expertise in pharmaceutical compositions and diagnostics has positioned her as a key figure in her field.
Collaborations
Throughout her career, Ann has collaborated with notable colleagues, including Shuk-Man Ka and Kuo-Feng Hua. These partnerships have enhanced her research and development efforts, leading to impactful inventions.
Conclusion
Ann Chen's innovative work in pharmaceuticals and diagnostics showcases her dedication to advancing medical science. Her contributions have the potential to improve treatment options for autoimmune diseases and enhance diagnostic accuracy for IgA nephropathy.